Nefs Giesje
Department of Medical Psychology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, Netherlands.
Diabeter, National Treatment and Research Center for Children, Adolescents and Adults With Type 1 Diabetes, Rotterdam, Netherlands.
Front Clin Diabetes Healthc. 2022 May 3;3:846162. doi: 10.3389/fcdhc.2022.846162. eCollection 2022.
Automated insulin delivery (AID) systems have brought important glycemic benefits to type 1 diabetes management. The present paper provides an overview of their psychological implications. Trials and real-world observational studies report improvements in diabetes-specific quality of life, with qualitative work describing reduced management burden, increased flexibility and improved relationships. Not all experiences are positive, however, evidenced by dropping algorithm use soon after device initiation. Apart from finance and logistics, reasons for discontinuation include technology frustrations, wear-related issues and unmet glycemic and work load expectations. New challenges include distrust in proper AID functioning, overreliance and deskilling, compensatory behaviors to override or trick the system and optimize time in range, and concerns related to wearing multiple devices on the body. Research efforts may focus on incorporating a diversity perspective, updating existing person-reported outcome measures according to new technology developments, addressing implicit or explicit health professional bias in technology access, examining the merits of incorporating stress reactivity in the AID algorithm, and developing concrete approaches for psychological counseling and support related to technology use. An open dialogue with health professionals and peers about expectations, preferences and needs may foster the collaboration between the person with diabetes and the AID system.
自动胰岛素输送(AID)系统为1型糖尿病管理带来了重要的血糖控制益处。本文概述了其心理影响。试验和现实世界观察性研究报告了糖尿病特异性生活质量的改善,定性研究描述了管理负担减轻、灵活性增加以及人际关系改善。然而,并非所有体验都是积极的,设备启动后不久算法使用率下降就证明了这一点。除了财务和后勤方面,停用的原因还包括技术挫折、与佩戴相关的问题以及未满足的血糖和工作量期望。新的挑战包括对AID正常运行的不信任、过度依赖和技能退化、为超越或欺骗系统并优化血糖达标时间的代偿行为,以及与在身体上佩戴多个设备相关的担忧。研究工作可侧重于纳入多样性视角、根据新技术发展更新现有的患者报告结局指标、解决技术获取方面隐含或明确的卫生专业人员偏见、研究在AID算法中纳入应激反应性的优点,以及开发与技术使用相关的心理咨询和支持的具体方法。与卫生专业人员和同行就期望、偏好和需求进行开放对话,可能会促进糖尿病患者与AID系统之间的合作。